PetMed Express holds Q3 FY2023 earnings call; no financial details in provided text

PETMED EXPRESS INC

2023-Q3 EPS reported $0.26 revenue$187,782,000

Company held conference call on Feb 6, 2023 to discuss quarter ended Dec 31, 2022.
Transcript furnished as Exhibit 99.1 but not fully provided in this extract.
No specific revenue, EPS, or guidance figures available from the given filing text.
Forward-looking statements caution about risks including PetCareRx acquisition completion.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.7

PETMED EXPRESS INC reported financial results for quarter ended December 31, 2022.

Period: quarter ended December 31, 2022
Result: reported results

Exact text from the filing

On February 6, 2023, PetMed Express, Inc. (the “Company”) held a conference call to discuss its financial results for the quarter ended on December 31, 2022.

View on SEC.gov

38 earnings releases filed in the last 30 days. Browse all earnings releases →

PETMED EXPRESS INC filing history →

Source: SEC EDGAR

accession 0001040130-23-000015

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.